Request Demo
Last update 02 Aug 2025
SDT-101
Last update 02 Aug 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SDT-101马来酸盐, SDT 101, SDT-101 + [1] |
Target |
Action inhibitors |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with SDT-101CTR20200177
SDT-101马来酸盐胶囊在晚期恶性实体瘤患者中单次给药和多次连续给药的 I 期临床试验
[Translation] Phase I clinical trial of single and multiple continuous administration of SDT-101 maleate capsules in patients with advanced malignant solid tumors
100 Clinical Results associated with SDT-101
Login to view more data
100 Translational Medicine associated with SDT-101
Login to view more data
100 Patents (Medical) associated with SDT-101
Login to view more data
100 Deals associated with SDT-101
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 15 May 2020 | |
| Breast Cancer | IND Application | China | 29 Nov 2019 | |
| Glioblastoma | IND Application | China | 29 Nov 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free